Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients-Reference-Cited by-同舟云学术

Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients

Published:2011 Issue:4 Volume:17 Page:CR196-CR202
ISSN:1234-1010
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Piotrowska Ewa¹,Jakobkiewicz-Banecka Joanna¹,Maryniak Agnieszka²,Tylki-Szymanska Anna²,Puk Ewa³,Liberek Anna⁴,Wegrzyn Alicja⁵,Czartoryska Barbara⁶,Slominska-Wojewodzka Monika¹,Wegrzyn Grzegorz¹

Affiliation:

1. Department of Molecular Biology, University of Gdansk, Gdansk, Poland

2. The Children’s Memorial Health Institute, Warsaw, Poland

3. Biofarm, Poznan, Poland

4. Department of Pediatrics, Pediatric Gastroenterology, Hepatology and Nutrition, Medical University of Gdansk, Gdansk, Poland

5. Laboratory of Molecular Biology (affiliated with the University of Gdansk), Instituite of Biochemistry and Biophysics, Polish Academy of Sciences, Gdansk, Poland

6. Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Concepts in the Management of Sanfilippo Syndrome (MPS III): A Narrative Review;Cureus;2024-04-11

2. Safety and Efficacy of Genistein in Sanfilippo Syndrome - A Systematic Review;Current Drug Therapy;2023-08

3. Prospects of using biologically active substances to prevent depression;Nutrition Science, Marketing Nutrition, Health Claims, and Public Policy;2023

4. Hopes and disappointments related to the use of flavonoids in therapeutical approaches;Modulation of Oxidative Stress;2023

5. Murine Fibroblasts and Primary Hepatocytes as Tools When Studying the Efficacy of Potential Therapies for Mucopolysaccharidosis Type I;International Journal of Molecular Sciences;2022-12-28